Billable / Specific Code
ICD-10-CM C13.1 is the diagnosis code for Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect. This code falls under the section "Malignant neoplasms of lip, oral cavity and pharynx" within Chapter 2 â Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in C13.1. If the patient has both, code each condition separately:
Understanding where C13.1 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C13.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C13.1 is the ICD-10-CM diagnosis code for "Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C13.1 is C13 ("Malignant neoplasm of hypopharynx"). C13.1 provides a more specific classification within this category.
C13.1 is located in Section C00-C14 â "Malignant neoplasms of lip, oral cavity and pharynx" within Chapter 2 of the ICD-10-CM Tabular List.
Use C13.1 when the patients documented diagnosis matches "Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect is C13.1.
Yes, C13.1 can be used as a primary diagnosis code since it is billable and specific.
C13.1 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C13.1 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.